Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects
Clinical trial NCT03014089 · COMPLETED
Trial details
- NCT number
- NCT03014089
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-21
- Primary completion
- 2019-07-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.